2024 Q2 Form 10-Q Financial Statement

#000107997324001458 Filed on October 30, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q2
Revenue $0.00 $495.4K
YoY Change -100.0% -11.19%
Cost Of Revenue $241.1K
YoY Change -17.62%
Gross Profit $254.3K
YoY Change -4.09%
Gross Profit Margin 51.33%
Selling, General & Admin $315.3K
YoY Change -9.7%
% of Gross Profit 123.99%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $43.53K
YoY Change 6.43%
% of Gross Profit 17.12%
Operating Expenses $1.313M $320.4K
YoY Change 309.85% -9.66%
Operating Profit -$1.313M -$66.10K
YoY Change 1886.48% -26.15%
Interest Expense $1.504K $12.62K
YoY Change -88.09% 32.65%
% of Operating Profit
Other Income/Expense, Net $207.1K -$1.572K
YoY Change -13274.94% -101.48%
Pretax Income -$1.106M $17.02K
YoY Change -6597.72% 143.84%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$1.106M $17.02K
YoY Change -6596.58% 143.99%
Net Earnings / Revenue 3.44%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 530.1M shares 28.04M shares
Diluted Shares Outstanding 530.7M shares 37.09M shares

Balance Sheet

Concept 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $72.66K
YoY Change 141.64%
Cash & Equivalents $116.3K $72.66K
Short-Term Investments
Other Short-Term Assets $33.82K
YoY Change -59.33%
Inventory $18.35K
Prepaid Expenses $26.69K
Receivables $246.2K
Other Receivables $0.00
Total Short-Term Assets $143.0K $371.0K
YoY Change -61.47% -21.63%
LONG-TERM ASSETS
Property, Plant & Equipment $83.52K
YoY Change -65.42%
Goodwill $145.1K
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $4.209K $316.4K
YoY Change -98.67% -35.65%
TOTAL ASSETS
Total Short-Term Assets $143.0K $371.0K
Total Long-Term Assets $4.209K $316.4K
Total Assets $147.2K $687.4K
YoY Change -78.59% -28.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $271.5K $201.7K
YoY Change 34.64% 41.26%
Accrued Expenses $91.47K
YoY Change -18.44%
Deferred Revenue
YoY Change
Short-Term Debt $3.846M
YoY Change 1210.26%
Long-Term Debt Due $18.13K
YoY Change 14.68%
Total Short-Term Liabilities $4.337M
YoY Change 4.33%
LONG-TERM LIABILITIES
Long-Term Debt $163.2K
YoY Change -38.23%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $163.2K
YoY Change -38.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.337M
Total Long-Term Liabilities $163.2K
Total Liabilities $836.2K $4.501M
YoY Change -81.42% 1.79%
SHAREHOLDERS EQUITY
Retained Earnings -$6.627M -$99.35M
YoY Change -93.33% 0.36%
Common Stock $530.7K $28.04K
YoY Change 1792.81% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$689.0K -$3.813M
YoY Change
Total Liabilities & Shareholders Equity $147.2K $687.4K
YoY Change -78.59% -28.77%

Cashflow Statement

Concept 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income -$1.106M $17.02K
YoY Change -6596.58% 143.99%
Depreciation, Depletion And Amortization $43.53K
YoY Change 6.43%
Cash From Operating Activities -$22.63K
YoY Change -23.65%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 69.27K
YoY Change -28.17%
NET CHANGE
Cash From Operating Activities -22.63K
Cash From Investing Activities 0.000
Cash From Financing Activities 69.27K
Net Change In Cash 46.64K
YoY Change -1213.13%
FREE CASH FLOW
Cash From Operating Activities -$22.63K
Capital Expenditures $0.00
Free Cash Flow -$22.63K
YoY Change -154.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 vyey Loan From Shareholders
LoanFromShareholders
125830 usd
CY2023Q4 vyey Loan From Shareholders
LoanFromShareholders
145830 usd
CY2024Q2 us-gaap Liabilities
Liabilities
836194 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1528000 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
530704753 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
530704753 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
418822708 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
418822708 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
530707 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
418823 usd
CY2024Q2 vyey Shares To Be Issued
SharesToBeIssued
24 usd
CY2023Q4 vyey Shares To Be Issued
SharesToBeIssued
0 usd
CY2024Q2 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
245000 usd
CY2023Q4 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
-0 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5652124 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6626879 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1699602 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-689024 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1280779 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
147170 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
247221 usd
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2024Q2 us-gaap Revenues
Revenues
0 usd
CY2023Q2 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2024Q2 vyey Consulting Expenses
ConsultingExpenses
186496 usd
CY2023Q2 vyey Consulting Expenses
ConsultingExpenses
0 usd
vyey Consulting Expenses
ConsultingExpenses
4137558 usd
vyey Consulting Expenses
ConsultingExpenses
0 usd
CY2024Q2 vyey Licensing Fees
LicensingFees
600000 usd
CY2023Q2 vyey Licensing Fees
LicensingFees
0 usd
vyey Licensing Fees
LicensingFees
600000 usd
vyey Licensing Fees
LicensingFees
0 usd
CY2024Q2 vyey Personnel Expenses
PersonnelExpenses
258873 usd
CY2023Q2 vyey Personnel Expenses
PersonnelExpenses
23716 usd
vyey Personnel Expenses
PersonnelExpenses
557242 usd
vyey Personnel Expenses
PersonnelExpenses
39932 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
185030 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5723 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
377449 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19304 usd
CY2024Q2 us-gaap Professional Fees
ProfessionalFees
82623 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
15000 usd
us-gaap Professional Fees
ProfessionalFees
180584 usd
us-gaap Professional Fees
ProfessionalFees
15000 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
1313022 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
44439 usd
us-gaap Operating Expenses
OperatingExpenses
5852833 usd
us-gaap Operating Expenses
OperatingExpenses
74236 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1313022 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-44439 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5852833 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-74236 usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2473 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1572 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
6432 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2868 usd
CY2024Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
209583 usd
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1260782 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024Q2 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
0 usd
CY2023Q2 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
0 usd
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
-328794 usd
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
0 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
207110 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1572 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
925556 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2868 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1105912 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-46011 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4927277 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-77104 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1105912 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-46011 usd
us-gaap Net Income Loss
NetIncomeLoss
-4927277 usd
us-gaap Net Income Loss
NetIncomeLoss
-77104 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
530704753 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
530704753 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
418822708 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
418822708 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
526721203 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
526721203 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
418822708 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
418822708 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1280779 usd
CY2024Q1 vyey Conversion Of Notes Payable Prior To Recapitalization
ConversionOfNotesPayablePriorToRecapitalization
4093756 usd
CY2024Q1 vyey Effects Of Recapitalization
EffectsOfRecapitalization
-4087427 usd
CY2024Q1 vyey Conversion Of Notes Payable Post Recapitalization
ConversionOfNotesPayablePostRecapitalization
185000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
401655 usd
CY2024Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
3483548 usd
CY2024Q1 vyey Sale Of Series E Preferred Stock
SaleOfSeriesEPreferredStock
250000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-3821365 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-775612 usd
CY2024Q2 vyey Sale Of Series E Preferred Stock
SaleOfSeriesEPreferredStock
1192500 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1105912 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-689024 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-25420 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-31093 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-56513 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-46011 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-102524 usd
us-gaap Net Income Loss
NetIncomeLoss
-4927277 usd
us-gaap Net Income Loss
NetIncomeLoss
-77104 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
2358 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
2360 usd
vyey Stock Issued For Services
StockIssuedForServices
384693 usd
vyey Stock Issued For Services
StockIssuedForServices
0 usd
vyey Warrants Issued For Services
WarrantsIssuedForServices
3483548 usd
vyey Warrants Issued For Services
WarrantsIssuedForServices
0 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
9732 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
55733 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
0 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
52796 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
14037 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-957881 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-60707 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
774006 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-774006 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
1442500 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
185000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
35000 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-20000 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1607500 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
35000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-124387 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-25707 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
240654 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26480 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
116267 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
773 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
vyey Conversion Of Notes Payable
ConversionOfNotesPayable
4278756 usd
vyey Conversion Of Notes Payable
ConversionOfNotesPayable
0 usd
vyey Gain On Forgiveness Of Debt
GainOnForgivenessOfDebt
1260782 usd
vyey Gain On Forgiveness Of Debt
GainOnForgivenessOfDebt
0 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_84E_eus-gaap--NatureOfOperations_zAfaXzp2hPe5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_867_zKbonR02xTxl">Organization and nature of operations</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Victory Clean Energy, Inc., formerly Victory Oilfield Tech, Inc. (“Victory”), a Nevada corporation, has historically operated as an oilfield technology products company offering patented oil and gas drilling products. On July 31, 2018, Victory entered into an agreement to acquire Pro-Tech Hardbanding Services, Inc., an Oklahoma corporation (“Pro-Tech”), which provides various hardbanding solutions to oilfield operators for drill pipe, weight pipe, tubing and drill collars.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 1, 2024, Victory completed a merger agreement with H2 Energy Group Inc., a Delaware corporation (“H2EG”) (the “Merger”). As a result of the Merger, a change in control of Victory occurred, and H2EG became a wholly owned subsidiary of Victory. On January 1, 2024, Victory completed the sale of Pro-Tech to Flagstaff International, LLC, a Delaware limited liability company. On January 11, 2024, Victory amended its Articles of Incorporation to authorize <span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_iI_c20240111_z5dk96Kyh3c2" title="Common stock, shares authorized">2,000,000,000</span> common shares and change its name to Victory Clean Energy, Inc.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">H2EG uses scalable and modular technology to produce low-cost hydrogen-rich syngas from renewable woody biomass. The Company plans to construct a renewable hydrogen production facility and install four hydrogen refueling stations in California.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6626879 usd
CY2024Q2 vyey Working Capital Deficit
WorkingCapitalDeficit
-693233 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_849_eus-gaap--UseOfEstimates_zItGYkWUoUQ5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_868_zGtMDiwEhJVi">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Estimates are used primarily when accounting for depreciation and amortization expense, various common stock, warrants and option transactions, evaluation of intangible assets, and loss contingencies.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zZ2KHjrwLwzb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_860_zToeVO8d3AFl">Concentration of Credit Risk</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, and accounts receivable. The Company places its cash equivalents with financial institutions and invests its excess cash primarily in certificates of deposit, deposit accounts or treasury bills. The Company has established guidelines relative to credit ratings and maturities that seek to maintain stability and liquidity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i> </i></b></p>
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
7492 usd
CY2022Q4 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
6660 usd
us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2358 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2358 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1179 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1179 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3859759 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
102284990 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
102284990 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2024Q2 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
14152 usd
CY2023Q4 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
14152 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9943 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7585 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4209 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6567 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2358 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1179 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1179 usd
us-gaap Interest Expense
InterestExpense
3409 usd
us-gaap Interest Expense
InterestExpense
2868 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
1504 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
1590 usd
CY2024Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.04
CY2024Q2 us-gaap Advances To Affiliate
AdvancesToAffiliate
1442500 usd
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
418822708 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2024Q2 us-gaap Share Price
SharePrice
0.059
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.059
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7417 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0393 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
CY2023Q4 vyey Monthly Fee
MonthlyFee
15000 usd
vyey Consulting Agreement Compensation
ConsultingAgreementCompensation
90000 usd
vyey Consulting Agreement Compensation
ConsultingAgreementCompensation
0 usd
CY2024Q2 vyey Consulting Agreement Compensation
ConsultingAgreementCompensation
45000 usd
CY2023Q2 vyey Shares Based Compensation
SharesBasedCompensation
0 usd
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
4000000 usd
CY2024Q1 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
328794 usd
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001079973-24-001458-index-headers.html Edgar Link pending
0001079973-24-001458-index.html Edgar Link pending
0001079973-24-001458.txt Edgar Link pending
0001079973-24-001458-xbrl.zip Edgar Link pending
ex31x1.htm Edgar Link pending
ex31x2.htm Edgar Link pending
ex32x1.htm Edgar Link pending
ex32x2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vyey-20240630.xsd Edgar Link pending
vyey-20240630_def.xml Edgar Link unprocessable
vyey_10q-063024.htm Edgar Link pending
vyey-20240630_pre.xml Edgar Link unprocessable
vyey-20240630_lab.xml Edgar Link unprocessable
vyey_10q-063024_htm.xml Edgar Link completed
vyey-20240630_cal.xml Edgar Link unprocessable